庄法安崎看得我好爽

Medipost Reports Positive Phase 3 Results for CARTISTEM in Japan’s Knee Osteoarthritis Trial_蜘蛛资讯网

alanced distribution of key factors between the groups, including average patient age (61.3 years for CARTISTEM, 62.2 years for control), osteoarthritis severity indicators like Kellgren–Lawrenc

中率54.9%。                                    数说NBA2025-26

apan. The results confirmed significant improvements in clinical pain relief, functional recovery, and cartilage regeneration. This breakthrough demonstrates Medipost's global competitiveness in Japan

当前文章：http://yet7.ruocenqi.cn/vgn3b/59k.html

发布时间：00:00:00